UA72919C2 - Ароматичні аміди, заміщені рибозою, спосіб їх одержання та фармацевтична композиція - Google Patents

Ароматичні аміди, заміщені рибозою, спосіб їх одержання та фармацевтична композиція

Info

Publication number
UA72919C2
UA72919C2 UA2001117895A UA2001117895A UA72919C2 UA 72919 C2 UA72919 C2 UA 72919C2 UA 2001117895 A UA2001117895 A UA 2001117895A UA 2001117895 A UA2001117895 A UA 2001117895A UA 72919 C2 UA72919 C2 UA 72919C2
Authority
UA
Ukraine
Prior art keywords
alkyl
hydrogen
ribose
preparation
pharmaceutical composition
Prior art date
Application number
UA2001117895A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Жак Демассе
Мішель Кліш
Браніслав Мусіцкі
Original Assignee
Авентіс Фарма С.А.
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентіс Фарма С.А., Авентис Фарма С.А. filed Critical Авентіс Фарма С.А.
Publication of UA72919C2 publication Critical patent/UA72919C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/075Benzo[b]pyran-2-ones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
UA2001117895A 1999-04-19 2000-04-18 Ароматичні аміди, заміщені рибозою, спосіб їх одержання та фармацевтична композиція UA72919C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904866A FR2792320B1 (fr) 1999-04-19 1999-04-19 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
PCT/FR2000/000999 WO2000063222A2 (fr) 1999-04-19 2000-04-18 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
UA72919C2 true UA72919C2 (uk) 2005-05-16

Family

ID=9544554

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001117895A UA72919C2 (uk) 1999-04-19 2000-04-18 Ароматичні аміди, заміщені рибозою, спосіб їх одержання та фармацевтична композиція

Country Status (24)

Country Link
US (1) US6579902B1 (enExample)
EP (1) EP1173455A2 (enExample)
JP (1) JP2002542253A (enExample)
KR (1) KR100693258B1 (enExample)
CN (1) CN1213055C (enExample)
AP (1) AP2001002312A0 (enExample)
AU (1) AU769514B2 (enExample)
CA (1) CA2363945A1 (enExample)
CZ (1) CZ20013708A3 (enExample)
EA (1) EA004304B1 (enExample)
FR (1) FR2792320B1 (enExample)
HK (1) HK1046690B (enExample)
HU (1) HUP0200778A3 (enExample)
ID (1) ID30562A (enExample)
IL (1) IL146018A0 (enExample)
NO (1) NO320703B1 (enExample)
NZ (1) NZ515108A (enExample)
PL (1) PL354192A1 (enExample)
SK (1) SK14842001A3 (enExample)
TR (1) TR200103009T2 (enExample)
UA (1) UA72919C2 (enExample)
WO (1) WO2000063222A2 (enExample)
YU (1) YU80301A (enExample)
ZA (1) ZA200108627B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
KR100649357B1 (ko) * 2004-05-04 2006-11-24 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
US8212011B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues
US9120774B2 (en) 2004-11-03 2015-09-01 University Of Kansas Novobiocin analogues having modified sugar moieties
US7608594B2 (en) * 2004-11-03 2009-10-27 University Of Kansas Novobiocin analogues as anticancer agents
US7622451B2 (en) * 2004-11-03 2009-11-24 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
US8212012B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues having modified sugar moieties
US7960353B2 (en) * 2007-05-10 2011-06-14 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
WO2010014617A1 (en) * 2008-07-28 2010-02-04 University Of Kansas Heat shock protein 90 inhibitor dosing methods
US20110082098A1 (en) * 2009-09-30 2011-04-07 University Of Kansas Novobiocin analogues and treatment of polycystic kidney disease
US11827664B2 (en) 2018-05-14 2023-11-28 Reata Pharmaceuticals, Inc Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652536A (en) * 1969-06-02 1972-03-28 Upjohn Co Novenamine compounds and derivatives
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine

Also Published As

Publication number Publication date
EA004304B1 (ru) 2004-02-26
EA200101100A1 (ru) 2002-04-25
AP2001002312A0 (en) 2001-12-31
FR2792320B1 (fr) 2003-05-09
WO2000063222A3 (fr) 2001-05-31
NO20015058L (no) 2001-12-17
YU80301A (sh) 2005-07-19
FR2792320A1 (fr) 2000-10-20
HUP0200778A3 (en) 2003-03-28
IL146018A0 (en) 2002-07-25
AU769514B2 (en) 2004-01-29
PL354192A1 (en) 2003-12-29
ZA200108627B (en) 2002-10-21
KR20020008155A (ko) 2002-01-29
CA2363945A1 (fr) 2000-10-26
TR200103009T2 (tr) 2002-05-21
HK1046690A1 (en) 2003-01-24
NZ515108A (en) 2004-01-30
ID30562A (id) 2001-12-20
WO2000063222A2 (fr) 2000-10-26
EP1173455A2 (fr) 2002-01-23
CZ20013708A3 (cs) 2002-04-17
CN1357001A (zh) 2002-07-03
KR100693258B1 (ko) 2007-03-13
US6579902B1 (en) 2003-06-17
JP2002542253A (ja) 2002-12-10
HUP0200778A2 (hu) 2002-07-29
SK14842001A3 (sk) 2003-05-02
NO320703B1 (no) 2006-01-16
AU4125600A (en) 2000-11-02
CN1213055C (zh) 2005-08-03
HK1046690B (zh) 2006-03-10
NO20015058D0 (no) 2001-10-18

Similar Documents

Publication Publication Date Title
MY126951A (en) Beta2-adrenoceptor agonists
UA72919C2 (uk) Ароматичні аміди, заміщені рибозою, спосіб їх одержання та фармацевтична композиція
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
GEP20063915B (en) PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS AND USE THEREOF FOR TREATING p38 KINASE-ASSOCIATED CONDITIONS
ES2187473T3 (es) Triarylimidazoles.
NZ506679A (en) HIV inhibiting pyrimidine derivatives
IL110091A (en) POLYSUBSTITUTED IMIDAZO £4, 5-c| PYRIDIN-4-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO20075312L (no) N-(N-sulfonylaminometyl)cyklopropankarboksamidderivater nyttige ved smertebehandling
HUP0301387A2 (hu) Szintetikus módszerek aplidin és új tumorellenes származékok előállítására
IL158343A (en) Dopamine glycoconjugate compounds, pharmaceutical compositions comprising them, processes for their preparation and use thereof in the manufacture of medicaments and as medicaments for treating parkinson's disease
DE60107435D1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
GR3029471T3 (en) 2-substituted quinolines for treating leishmanioses.
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
HUP0500203A2 (hu) Acil-3-karboxi-fenil-karbamid-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO941516L (no) 3-kinolylsubstituerte dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
MXPA05009607A (es) Derivados de n-fenil-[(4-piridil)-azinil]-amina como agentes protectores de plantas.
NO994104L (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
HRP990130B1 (en) HALOGEN DERIVATIVES 9a-N-(N'-ARYLCARBAMOYL)- AND 9a-N-(N'-ARYLTHIOCARBAMOYL)-9-DEOXO-9a-AZA-9a OF HOMOERYTHROMYCIN A
UA41348C2 (uk) Проліки 3-ацил-2-оксіндол-1-карбоксамідів та фармацевтична композиція
PT1230223E (pt) Derivados de oligobenzimidazoles e a sua utilizacao como agentes de transfeccao de adn
TWI263639B (en) Novel tetrazole derivative
TW330147B (en) Halogenobenzimidazoles, their preparation processes and their use
NZ291855A (en) Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists
NZ504299A (en) 1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them